Home/Filings/4/0000914190-15-000339
4//SEC Filing

Cardiovascular Systems Inc 4

Accession 0000914190-15-000339

CIK 0001180145operating

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 4:38 PM ET

Size

13.5 KB

Accession

0000914190-15-000339

Insider Transaction Report

Form 4
Period: 2015-08-17
Martin David
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2015-08-17$24.01/sh9,780$234,827507,068 total
  • Sale

    Common Stock

    2015-08-18$23.97/sh7,908$189,564499,160 total
Holdings
  • Common Stock

    (indirect: By Children)
    350
  • Common Stock

    (indirect: By Children)
    850
  • Stock Option (right to buy)

    Exercise: $12.15Exp: 2017-12-11Common Stock (234,395 underlying)
    234,395
  • Stock Option (right to buy)

    Exercise: $8.75Exp: 2019-03-01Common Stock (32,350 underlying)
    32,350
  • Stock Option (right to buy)

    Exercise: $7.90Exp: 2017-06-11Common Stock (90,580 underlying)
    90,580
  • Common Stock

    (indirect: By Children)
    850
Footnotes (4)
  • [F1]In connection with the vesting and delivery of restricted stock and pursuant to a Rule 10b5-1 trading plan, on the date the shares were sold the net proceeds were used to pay required withholding taxes.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.93 to $24.12 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.82 to $24.09 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]Fully exercisable.

Issuer

Cardiovascular Systems Inc

CIK 0001180145

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001180145

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 4:38 PM ET
Size
13.5 KB